Parama dey
Parama dey
Ph.D Student
Verified email at
Cited by
Cited by
An update on pharmacological potential of boswellic acids against chronic diseases
NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ...
International journal of molecular sciences 20 (17), 4101, 2019
Targeting AKT/mTOR in oral cancer: Mechanisms and advances in clinical trials
C Harsha, K Banik, HL Ang, S Girisa, R Vikkurthi, D Parama, V Rana, ...
International journal of molecular sciences 21 (9), 3285, 2020
Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@ erGO) nanocomposite for selective detection of Parkinson's disease biomarker
G Mathew, P Dey, R Das, SD Chowdhury, MP Das, P Veluswamy, ...
Biosensors and Bioelectronics 115, 53-60, 2018
Inflammation, NF-κB, and chronic diseases: how are they linked?
AB Kunnumakkara, B Shabnam, S Girisa, C Harsha, K Banik, TB Devi, ...
Critical Reviews™ in Immunology 40 (1), 2020
Diosgenin, a steroidal saponin, and its analogues: Effective therapies against different chronic diseases
D Parama, M Boruah, Y Kumari, V Rana, K Banik, C Harsha, KK Thakur, ...
Life sciences, 118182, 2020
COVID-19, cytokines, inflammation, and spices: How are they related?
AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, H Sahu, ...
Life sciences, 119201, 2021
Rationalizing the therapeutic potential of apigenin against cancer
SA Ahmed, D Parama, E Daimari, S Girisa, K Banik, C Harsha, U Dutta, ...
Life Sciences, 118814, 2020
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
UD Daimary, D Parama, V Rana, K Banik, A Kumar, C Harsha, ...
Current Research in Pharmacology and Drug Discovery, 100008, 2020
Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
S Girisa, D Parama, C Harsha, K Banik, AB Kunnumakkara
Exploration of Targeted Anti-tumor Therapy 1 (5), 313-342, 2020
From Simple Mouth Cavities to Complex Oral Mucosal Disorders—Curcuminoids as a Promising Therapeutic Approach
S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ...
ACS pharmacology & translational science 4 (2), 647-665, 2021
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
S Girisa, S Henamayee, D Parama, V Rana, U Dutta, AB Kunnumakkara
Molecular Biomedicine 2 (1), 1-23, 2021
Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation …
M Aswathy, K Banik, D Parama, P Sasikumar, C Harsha, AG Joseph, ...
ACS Pharmacology & Translational Science 4 (2), 834-847, 2021
Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ...
Journal of Functional Foods 86, 104660, 2021
Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases
ABK Aviral Kumar, Choudhary Harsha, Dey Parama, Sosmitha Girisa, Uzni Devi ...
Phytotherapy Research, 2021
Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells.
S Girisa, V Rana, D Parama, U Dutta, AB Kunnumakkara
Advances in Protein Chemistry and Structural Biology 126, 63-90, 2021
Oxidative Stress and Inflammation
V Rana, D Parama, S Girisa, C Harsha, AB Kunnumakkara
Antioxidants and Functional Foods for Neurodegenerative Disorders, 21-36, 2021
The Promising Potential of Piperlongumine as an Emerging Therapeutics for Cancer
ABK Dey Parama, Varsha Rana, Sosmitha Girisa, Elika Verma, Uzini Devi ...
Explor Target Antitumor Ther, 2021
The system can't perform the operation now. Try again later.
Articles 1–17